Visualize PIM‐1 Protein Function and Its Interaction With PI3K/Akt/mTOR Pathway Regulated by Its Active Sites Through FRET Biosensors
Authors:
- 18 December 2024
- journal article
- research article
- Published by Wiley in Biotechnology Journal
- Vol. 19 (12) , e202400443
Abstract
Pro‐viral Insertion site for the Moloney Murine Leukemia virus 1 (PIM‐1) is widely involved in various biological processes and diseases, which is based on its structure and functional sites. However, the relationship between active sites and function of PIM‐1 kinase remains unclear due to the lack of effective study approaches in live cells. Herein, to visualize the effect of different active sites in PIM‐1 protein on its function activity and relation with PI3K/Akt/mTOR pathway, three mutant probes of EPHY which was developed previously based on fluorescence resonance energy transfer (FRET) technology to detect PIM‐1 kinase activity in living cells were further constructed and transfected into cells followed by treating with PIM‐1 inhibitors, ATP and PI3K inhibitor, respectively. The results showed that Lys67 is related to substrate binding and catalytic activity of PIM‐1 kinase, thereby directly regulating PI3K/Akt/mTOR signaling pathway. Pro81/Asn82 are primarily participated in PIM‐1 binding to ATP, thus also involving in the modulation on PI3K/Akt/mTOR signaling pathway, but play less role in the interaction between PIM‐1 protein and its substrate. Asp167 has few effects on both the catalytic function activity of PIM‐1 and PI3K/AKT/mTOR pathway, even though the binding ability of PIM‐1 protein to its substrate is dramatically inhibited by D167A mutation. Altogether, the mutant probes works well as visualization tools to unearth the function of active sites in PIM‐1 kinase, not only facilitating the further clarification of molecular mechanism underlying PIM‐1 related signaling pathways, but also shedding light on drug development and disease therapy targeting PIM‐1 protein.Keywords
Funding Information
- National Natural Science Foundation of China (32071252)
- Fundamental Research Funds for the Central Universities (DUT22YG215, DUT24YG127)
This publication has 38 references indexed in Scilit:
- Ononin inhibits triple-negative breast cancer lung metastasis by targeting the EGFR-mediated PI3K/Akt/mTOR pathwayScience China Life Sciences, 2024
- Methylation of GPRC5A promotes liver metastasis and docetaxel resistance through activating mTOR signaling pathway in triple negative breast cancerDrug Resistance Updates, 2024
- Rosmarinic acid enhances CHO cell productivity and proliferation through activation of the unfolded protein response and the mTOR pathwayBiotechnology Journal, 2023
- Computational generation and characterization of IsdA‐binding aptamers with single‐molecule FRET analysisBiotechnology Journal, 2023
- Topical advances in PIM kinases and their inhibitors: Medicinal chemistry perspectivesBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2022
- Pim kinase inhibitors in cancer: medicinal chemistry insights into their activity and selectivityDrug Discovery Today, 2020
- PIM kinase inhibitors: Structural and pharmacological perspectivesEuropean Journal of Medicinal Chemistry, 2019
- PIM kinases: From survival factors to regulators of cell motilityThe International Journal of Biochemistry & Cell Biology, 2017
- PIM1: a promising target in patients with triple-negative breast cancerMedical Oncology, 2017
- Identification and structure–activity relationships of substituted pyridones as inhibitors of Pim-1 kinaseBioorganic & Medicinal Chemistry Letters, 2007